2cureX and University Hospital of Hamburg-Eppendorf present IndiTreat data at ESMO GI for early-stage Pancreatic Cancer
2cureX announces the presentation of the poster [P-288] “Individual Drug Screening and heterogeneity analysis of patient derived tumoroids – Roadmap to improving therapy in Pancreatic Cancer” at the 2021 ESMO World Congress on Gastrointestinal Cancer (ESMO GI) starting yesterday. The poster is presented jointly with the University Hospital of Hamburg - Eppendorf (UKE - Hamburg, Germany) as part of a collaboration to bring Functional Testing to Pancreatic Cancer.The poster confirms the feasibility of using Functional Testing on resected tissue samples coming from the primary tumor, opening